• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Kensing Acquires Vitae Naturals

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected

    United Plant Savers Launches First Film Festival
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kensing Acquires Vitae Naturals

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    United Plant Savers Launches First Film Festival
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Kensing Acquires Vitae Naturals

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development

    Botanical Gum for Kids Aims to Curb Sugar Cravings
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Nutrition21, LLC

    PhytoGaia Inc

    JRS Pharma

    Botanic Healthcare LLC

    Atlantia Clinical Trials
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Nutrition21, LLC

    PhytoGaia Inc

    JRS Pharma

    Botanic Healthcare LLC

    Atlantia Clinical Trials
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    GOED Reacts to Recent Research and Headlines on EPA and DHA

    Updated analysis found omega-3s correlated to risk reductions of cardiovascular mortality and coronary heart disease events by 8% and 9%, respectively.

    GOED Reacts to Recent Research and Headlines on EPA and DHA
    Despite a case for the cardiovascular health benefits of EPA and DHA, the UN has not designated a daily recommended nutritional value for omega-3s.
    Related CONTENT
    • Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure
    • High Blood DHA Levels Linked to 49% Reduced Risk of Alzheimer’s
    • Research Trends in Nutrition and Mental Health
    • Guardion Inks Testing Agreement with OmegaQuant
    • ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics
    By Mike Montemarano, Associate Editor03.09.20
    The Global Organization for EPA and DHA (GOED), a trade group comprised of leaders in the omega-3 industry, believes the way in which two simultaneously-released studies were publicized downplayed recent clincal affirmations supporting cardiovascular health benefits provided by fish oil supplementation. 
     
    Cochrane, an England-based non-profit research institute, recently backtracked on a prior study which challenged cardiovascular benefit claims of EPA and DHA, two long-chain omega-3 fatty acids (LCn3s) found in fish oil supplements.
     
    The original study, published in July 2018, analyzed a combined 79 randomized trials involving 112,059 people. It concluded that omega-3 consumption via popular supplement delivery methods “probably makes little or no difference to risk of cardiovascular events.”
     
    “They [researchers] found high certainty evidence that long-chain omega 3 fats had little or no meaningful effect on the risk of death from any cause,” the study authors wrote at the time. “The risk of death from any cause was 8.8% in people who had increased their intake of omega 3 fats, compared with 9% in people in the control groups.”
     
    “They also found that taking more long-chain omega 3 fats (including EPA and DHA), primarily through supplements probably makes little or no difference to risk of cardiovascular events, coronary heart deaths, coronary heart disease events, stroke or heart irregularities,” the researchers continued.
     
    At the time, Cochrane lead author Dr. Lee Hooper, who is a member of the World Health Organization Nutrition Guidance Expert Advisory group (NUGAG), said: “We can be confident in the findings of this review which go against the popular belief that long-chain omega 3 supplements protect the heart. This large systematic review included information from many thousands of people over long periods. Despite all this information, we don’t see any protective effects.”
     
    Quest for an NRV
    GOED noted this study took place shortly before the Food and Agricultural Organization (FAO) of the United Nations’ Codex Committee on Nutrition and Foods for Special Dietary Uses discontinued its work on the nutrient reference values (NRVs) of EPA and DHA.
     
    Nutrient reference values are international guidelines for recommended daily nutrient values, which are utilized for food and supplement labeling purposes. Many countries that do not currently have an NRV for EPA or DHA would likely adopt the NRV established by FAO. The WHO NUGAG’s gathering of research was a part of this process, however, GOED contended that research conducted was not a joint FAO/WHO process, and the FAO was not in a position to comment on the outcomes of the reviews.
     
    GOED said it hopes it can eventually pursue an NRV-NCD for EPA and DHA in the future, however, it would require a Codex member country to submit a proposal for new work at a future meeting pending the availability of new scientific evidence.
     
    Backtrack
    Changes in Cochrane’s conclusion on omega-3s came on Feb. 29 this year, when Cochrane added seven new trials to its analysis, bringing the number to 162,796 participants.
     
    Three of the seven new studies which yielded statistically significant evidence suggesting that fish oil offers cardiovascular health benefits were published shortly after the WHO-commissioned Cochrane meta-analysis. These three studies were also published just before the WHO Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) discontinued evaluating whether or not to establish a nutrient reference value (NRV) for EPA or DHA.
     
    “A Study of Cardiovascular Events in Diabetes (ASCEND) reported an 18% statistically significant reduction in risk of vascular death and a 21% risk reduction for coronary death in response to 840 mg EPA+DHA daily in patients with diabetes who are not known to have arterial disease,” GOED included in a list. “Vitamin D and Omega 3 Trial (VITAL) reports statistically significant risk reductions in total myocardial infarction (MI) (28%); total coronary heart disease (CHD) (17%); and fatal MI (50%) in response to 840 mg EPA+DHA daily. REDUCE-IT reports statistically significant risk reductions in the primary endpoint of major adverse cardiovascular events (MACE) (25%); cardiovascular death or nonfatal MI (25%); fatal or nonfatal MI (31%); and cardiovascular death (20%) in response to 3,840 mg EPA daily.”
     
    In the update, Cochrane reported that increasing long-chain omega-3s “slightly reduces the risk of coronary heart disease mortality and events,” citing positive findings that the risk reductions for cardiovascular mortality and coronary heart disease events were 8% and 9%, respectively.
     
    “The updated evidence suggests that increasing LCn3 slightly reduces CHD mortality and CHD events (previously the evidence suggested little to no effect),” the study authors wrote. “Our understanding of effects of LCn3 on other outcomes, and of ALA on all outcomes, has not altered.”
     
    Additionally, the authors wrote that high-certainty evidence suggested “increasing LCn3 reduced triglycerides by ˜15% in a dose-dependent way.”
     
    While three positive studies on fish oil’s cardiovascular benefits that were later incorporated into the meta-analysis were published shortly after Cochrane’s meta-analysis, and preceded the Codex Committee’s decision to discontinue work toward establishing an NRV for fish oils, the Codex Committee hadn’t taken the three studies into consideration, in spite of discussions with GOED. 
     
    “As we’ve learned over the last four years, this is not an easy endeavor and one that is not as grounded in science as we once thought,” GOED said in response to the outcome. “Regardless of GOED’s future decision to pursue an NRV-NCD for EPA+DHA, it’s clear that GOED needs to make a concerted effort to educate global government bodies about the benefits of omega-3s.”
     
    On the same day that Hooper updated the Cochrane meta-analysis, she also co-authored a study which found that, among 47 randomized controlled trials, increasing LCn3 has little or no effect on the rates of cancer diagnoses, cancer deaths, and that increasing total omega-3s and omega-6s may slightly increase risk of cancer diagnosis, and cancer death. However, the doses in some trials were very high, according to Cochrane.
     
    The risk increase, according to the authors, is that if 1,000 males increased their omega-3 intake, it would result in an extra three cases of prostate cancer per year. Separate from this study, approximately one in nine men is diagnosed with prostate cancer during his lifetime, according to American Cancer society estimates.
     
    On the concurrent research updates provided on Feb. 29, and some of the media coverage of the studies on heart benefits and cancer risk, GOED provided some thoughts about recent headlines, which appeared to have focused on the cancer risk claims despite the positive news of statistically significant findings related to fish oil and heart health.
     
    Essentially, the organization finds that comparing substantiated heart disease claims to statistically insignificant impact on cancer outcomes doesn’t follow logically.
     
    Chris Gearheart, director of GOED member communications and engagement, said that describing one health effect as “offsetting” another in the realm of nutritional supplements was unprecedented.
     
    “GOED found this highly questionable,” Gearheart said. “We hope consumers will hear about what her meta-analysis actually found—statistically significant 8% and 9% risk reductions for cardiovascular mortality and coronary heart disease events. It’s never been claimed that omega-3 consumption prevents cancer, so this meta-analysis does not really share anything new or surprising.”
     
    Related Searches
    • Omega 6s
    • Delivery
    • Omega 3s
    • fats
    Related Knowledge Center
    • World Markets
    • Research
    • Regulations
    Suggested For You
    Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure
    High Blood DHA Levels Linked to 49% Reduced Risk of Alzheimer’s High Blood DHA Levels Linked to 49% Reduced Risk of Alzheimer’s
    Research Trends in Nutrition and Mental Health Research Trends in Nutrition and Mental Health
    Guardion Inks Testing Agreement with OmegaQuant Guardion Inks Testing Agreement with OmegaQuant
    ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics
    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
    Choline Alone May Improve Maternal DHA Status During Pregnancy Choline Alone May Improve Maternal DHA Status During Pregnancy
    GNC Adds Products from The Honest Company, Hers, and Womaness GNC Adds Products from The Honest Company, Hers, and Womaness
    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
    Nutraceuticals for Men: Muscle Health and Performance Nutrition Nutraceuticals for Men: Muscle Health and Performance Nutrition
    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions
    GC Rieber VivoMega Announces Construction of New Facility GC Rieber VivoMega Announces Construction of New Facility
    Nuseed’s Omega-3 Canola Ingredients Succeed FDA Review For Human, Animal Safety Nuseed’s Omega-3 Canola Ingredients Succeed FDA Review For Human, Animal Safety
    Natural Products Expo West Returns: Product Spotlight Natural Products Expo West Returns: Product Spotlight

    Related Breaking News

    • Cardiovascular Health | Dietary Supplements | Medical Nutrition | Omega-3s | Research
      Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure

      Three Grams of Omega-3s May be Optimal Dose for Reducing Blood Pressure

      A review of 71 studies found a dose-dependent relationship between omega-3s and blood pressure reductions, most significant for those with hypertension.
      06.13.22

    • Breaking News | Cognitive Function | Medical Nutrition | Omega-3s | Research | Research News
      High Blood DHA Levels Linked to 49% Reduced Risk of Alzheimer’s

      High Blood DHA Levels Linked to 49% Reduced Risk of Alzheimer’s

      An observational study found the benefit in a population of 1,490 dementia-free participants aged 65 years and older.
      06.10.22

    • Cardiovascular Health | Mood Health & Sleep | Omega-3s | Probiotics & Prebiotics | Research | Weight Management/Weight Loss
      Research Trends in Nutrition and Mental Health

      Research Trends in Nutrition and Mental Health

      UKRI research fellow Dr. Joseph Firth discussed evidence supporting dietary habits and supplementation at Vitafoods Europe 2022.
      By Mike Montemarano, Associate Editor 06.06.22


    • Breaking News | Fatty Acids | Industry & Market News | Medical Nutrition | Testing
      Guardion Inks Testing Agreement with OmegaQuant

      Guardion Inks Testing Agreement with OmegaQuant

      The company will apply nutritional status tests for research on current and future products.
      06.02.22

    • Dietary Supplements | Healthcare Trends | Medical Nutrition
      ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics

      ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics

      Personalized approaches to nutrition intervention can benefit public health by pre-empting chronic and metabolic disease.
      By Greg Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 06.02.22

    Loading, Please Wait..
    Trending
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • High Blood DHA Levels Linked To 49% Reduced Risk Of Alzheimer’s
    • CoQ10 And Royal Jelly Supplementation May Improve High Intensity Exercise
    Breaking News
    • Kensing Acquires Vitae Naturals
    • CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    • Shiitake Mushroom Extract Appears Helpful in HPV Infections
    • Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    • United Plant Savers Launches First Film Festival
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kensing Acquires Vitae Naturals
    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Coatings World

    Latest Breaking News From Coatings World

    Giedre Serritslev Appointed Managing Director Teknos
    Sheboygan Paint Company Adds Rosey Malchow as Customer Experience Manager
    PPG to Announce Second Quarter 2022 Results July 21
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Simon Johnson Appointed as Senior Business Development VP at MedAcuity
    Foster Corporation Named Marketing Partner for AdvanSource Biomaterials
    Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Phastar Appoints Chris Schoonmaker as Chief Operations Officer
    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
    EQT Private Equity Acquires SPT Labtech from Battery Ventures
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Highlights from Paris Packaging Week
    Walgreens Boots Alliance Decides Not to Sell Boots and No7 Beauty Company Businesses
    WWP Beauty Unveils New Packaging Collections in Collaboration with Eastman
    Happi

    Latest Breaking News From Happi

    Old Spice X Arby's Collab Conquers the Meat Sweats
    Sequential Wins New Grant To Propel Skin Microbiome Research
    Evonik Holds Groundbreaking Ceremony for Commercial Rhamnolipid Production Facility
    Ink World

    Latest Breaking News From Ink World

    Temporary Content Title
    Amcor Lift-Off Initiative Shortlists Start-ups for Seed Funding
    Barentz Highlights Lincoln MFG’s New ISO 9001:2015 Certification
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Sibress launches FADS3D flexo plate measuring device
    Mike Brown appointed VP for Davis-Standard’s Canadian operations
    Constantia Flexibles introduces chemical resistant recycle-ready laminate
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Suominen Launches Hydraspun Reserve
    Richard Knowlson Receives Lifetime Technical Achievement Award
    Skylark Launches Thicker Label Closure Technology in North American
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AIP Researchers Develop Microfluidic-Based Soft Robotic Prosthetic
    David Sharp Named Global Marketing VP at Catalyst OrthoScience
    Tecomet Appoints Bill Dow as President & CEO
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Avery Dennison Launches New Dual-Frequency RFID Inlay
    Avery Dennison Highlights New Approach to Apparel with ADX Lab
    trinamiX Face Authentication Protects Users from Fraud Attacks During Mobile Payments

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login